Gerbera Therapeutics, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression
Phase 2
Recruiting
- Conditions
- Depression, PostpartumPost-partum DepressionPostnatal DepressionPostpartum DepressionPost-Natal Depression
- Interventions
- Drug: NORA520 Dose 1Drug: NORA520 Dose 2Drug: Placebo
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- DuKang Pharmaceuticals, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06285916
- Locations
- 🇺🇸
Pillar Clinical Research, Bentonville, Arkansas, United States
🇺🇸Advanced Research Center, Anaheim, California, United States
🇺🇸Alliance Research Institute, Canoga Park, California, United States
News
No news found